Skip to content

Author

Jennifer D. Wu

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

NK-Cell Engagers in Cancer Immunotherapy: Recent Advances, Translational Challenges, and Future Strategies

Priorities include matching engager design to tumor and effector biology, optimizing pharmacokinetic and pharmacodynamic properties, defining predictive biomarkers, and developing rational combinations that translate early responses into durable disease control.

Jennifer D. Wu · 0 citations
Open access Oct 2026

Antibody Targeting Soluble NKG2D Ligand MIC Enhances Adoptive T-Cell Therapy in an NK Cell-Dependent Mechanism

Background/Objectives: Antigen-specific adoptive CD8+ T-cell therapy has demonstrated promising clinical activity in selected cancers; however, its broader efficacy against solid tumors remains limited by the immunosuppressive tumor microenvironment (TME), which compromises the persistence and function of transferred T...

F. Basher, Tyler A. Smith, Mark P. Rubinstein et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.